2025年全球病毒诊断检测套组市场报告

近年来，病毒诊断检测套组市场呈现强劲成长势头，市场规模从2024年的162.6亿美元增至2025年的174.8亿美元，复合年增长率达7.5%。这段时期的成长归因于医疗保健支出的增加、全球旅行的增加、慢性病毒感染疾病的增加、家用检测套组需求的增加以及个人化医疗的发展。

预计未来几年病毒诊断检测套组市场规模将强劲成长，2029年将达到234亿美元，复合年增长率为7.6%。预测期内的成长归因于伊波拉病毒感染疾病的上升、出血热发生率的上升、病毒感染疾病盛行率的上升、呼吸道融合细胞病毒盛行率的上升以及肝炎盛行率的上升。预测期内的主要趋势包括技术进步、就地检验、人工智慧和数据分析、与数位健康记录的整合以及次世代定序。

病毒诊断检测套组是医疗实践中用于检测患者临床样本中病毒感染的设备。这些套件通常包含试剂、抗体或其他与特定病毒抗原或遗传物质相互作用并产生可测量讯号的物质。它们可以检测血液、唾液、鼻拭子和其他体液等样本中的病毒颗粒、抗原和遗传物质（例如 RNA 或 DNA）。

病毒诊断检测套组主要分为传统检测和快速检测。传统病毒诊断检测是基于实验室的成熟方法，包括培养病毒、检测病毒抗原和测量抗体反应。这些检测包括直接萤光抗体 (DFA) 检测、免疫层析检测、基于逆转录聚合酶聚合酵素链锁反应(rt-PCR) 的检测、凝集试验、固相检测和流通式检测。这些检测的最终用户包括实验室、诊所、医院等。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供了病毒诊断检测套组检测套组的市场统计数据，包括全球市场规模、各地区市场份额、竞争对手的市场份额、详细的病毒诊断检测套组检测套组检测套组市场、市场趋势和商业机会，为您提供在病毒诊断试剂盒行业取得成功所需的数据。这份病毒诊断检测套组研究报告透过对产业现状和未来状况的详细分析，为您提供了全面的观点。

未来五年7.6%的预测成长率，较我们先前对该市场的预测略有下降0.5%。下降的主要原因是美国与其他国家之间的关税影响。这种影响可能会直接影响美国，导致来自中国和韩国等关键地区的病毒抗原试剂和侧流检测组件的供应链中断，从而导致疫情爆发时检测试剂短缺和诊断成本增加。

病毒感染疾病的日益普及预计将在未来几年推动病毒诊断检测套组市场的成长。病毒感染疾病是由侵入宿主细胞并在其中复製的微观病毒引起的，引起的症状从轻微到严重不等，并影响身体的各个部位。感染疾病的增加是由于全球旅行、都市化、影响媒介传播感染疾病的气候变迁以及能够引起疫情或传播到新地区的新病毒株的出现等因素造成的。病毒诊断检测套组透过检测血液、唾液和鼻拭子等生物样本中的病毒核酸（RNA 或 DNA）、抗原和抗体，在识别和确认特定病毒感染方面发挥关键作用。例如，根据美国疾病管制与预防中心 (CDC) 的数据，2022 年美国新增报告急性乙型肝炎病例 2,126 例，另有 16,729 例慢性B型肝炎病例。此外，美国14 个司法管辖区的急性乙型肝炎发病率高于全国平均水平，凸显了对有效诊断工具的需求。因此，病毒感染疾病的日益普及是病毒诊断检测检测套组市场成长的主要驱动力。

为了保持竞争力，病毒诊断检测检测套组市场的主要企业正专注于开发病毒检测试剂套件等创新产品。病毒检测套件是一种诊断工具，旨在检测生物样本中的特定病毒，提供快速准确的结果并支持有效的疾病监测和管理。例如，2024 年 8 月，英国的 BlueStain Global Ltd. 推出了 MPox 病毒检测套件。 BlueStain MPox 病毒检测套件是一种快速诊断测试，可快速且准确地识别 MPox 病毒，只需 15 到 30 分钟即可提供结果。该创新套件旨在透过及早发现和控制 MPox 疫情来改善公共卫生应对，特别是在资源有限的环境中。

2023年6月，英国生命科学公司Avacta Life Sciences以740万英镑（935万美元）收购了Coris Bioconcept。 Avacta的这项策略措施旨在透过增强其快速诊断检测产品组合来增强其在医疗诊断领域的能力，并扩大其市场影响力，尤其是在感染疾病控制和就地检验领域。 Coris Bioconcept总部位于比利时，专门从事快速诊断检测套组的开发和製造，主要专注于用于检测病毒和细菌病原体的横向流动检测。

病毒诊断检测套组市场包括病毒培养试剂套件、分子诊断试剂套件、抗体检测试剂套件、抗原检测套件和多重PCR套件的销售。该市场的价值为“出厂价”，即商品製造商或创造者出售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接出售给最终客户的商品价值。该市场中的商品价值还包括商品创造者出售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球病毒诊断检测套组：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 最终用途产业分析
• 全球病毒诊断检测套组市场：成长率分析
• 全球病毒诊断检测套组市场表现：规模与成长，2019-2024
• 全球病毒诊断检测套组市场预测：规模与成长，2024-2029年，2034年
• 全球病毒诊断检测套组：总目标市场（TAM）

第六章 市场细分

• 全球病毒诊断检测套组市场：检验、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 传统测试
• 快速检测
• 全球病毒诊断检测套组市场（依检测类型、效能及预测），2019-2024 年、2024-2029 年、2034 年
• 直接萤光抗体（DFA）检测
• 层析法法
• 基于逆转录聚合酵素链锁反应（RT-PCR）的检测
• 聚集试验
• 固相分析
• 流通分析
• 其他测试类型
• 全球病毒诊断检测套组市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
• 研究办公室
• 诊所
• 医院
• 其他最终用户
• 全球病毒诊断检测套组市场：按传统检测（按类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 酵素免疫分析法（ELISA）
• 聚合酵素链锁反应（PCR）检测
• 蛋白质印迹法
• 病毒培养检测
• 全球病毒诊断检测套组市场：依快速检测类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 横向流动化验（LFA）
• 免疫疾病层析试纸测试
• 逆转录环介导等温扩增（RT-LAMP）
• 快速抗原检测

第七章 区域和国家分析

• 全球病毒诊断检测套组市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球病毒诊断检测套组市场：按国家、实际结果和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 病毒诊断检测套组市场：竞争格局
• 病毒诊断检测套组市场：公司简介
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Becton Dickinson and Company
• Quest Diagnostics Incorporated
• Grifols SA
• Hologic Inc.
• PerkinElmer Inc.
• bioMerieux SA
• Quidel Corporation
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN NV
• Ortho Clinical Diagnostics
• Myriad Genetics Inc.
• Seegene Inc.
• OraSure Technologies Inc.
• Meridian Bioscience Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

• 2029年病毒诊断检测套组市场：提供新机会的国家
• 2029年病毒诊断检测套组市场：细分市场带来新机会
• 2029年病毒诊断检测套组市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章 附录

Viral diagnostic test kits are instruments used in medicine to detect viral infections in clinical samples from patients. These kits typically contain reagents, antibodies, or other substances that interact with specific viral antigens or genetic material, generating a measurable signal. They can detect viral particles, antigens, or genetic material (such as RNA or DNA) in samples such as blood, saliva, nasal swabs, or other bodily fluids.

The main types of viral diagnostic test kits include traditional tests and rapid tests. Traditional viral diagnostic tests are established laboratory-based methods that involve culturing the virus, detecting viral antigens, or measuring antibody responses. Examples of these tests include direct fluorescent antibody (DFA) tests, immunochromatographic assays, reverse transcriptase polymerase chain reaction (rt-PCR) based tests, agglutination assays, solid phase assays, flow through assays, and others. These tests are used by various end-users including research laboratories, clinics, hospitals, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The viral diagnostic test kits market research report is one of a series of new reports from The Business Research Company that provides viral diagnostic test kits market statistics, including viral diagnostic test kits industry global market size, regional shares, competitors with viral diagnostic test kits market share, detailed viral diagnostic test kits market segments, market trends, and opportunities, and any further data you may need to thrive in the viral diagnostic test kits industry. This viral diagnostic test kits research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The viral diagnostic test kits market size has grown strongly in recent years. It will grow from $16.26 billion in 2024 to $17.48 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing healthcare expenditure, increasing global travel, a rise in chronic viral infections, a rise in demand for home testing kits, and growth in personalized medicine.

The viral diagnostic test kits market size is expected to see strong growth in the next few years. It will grow to $23.4 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing Ebola virus infections, increasing hemorrhagic fever, rising prevalence of viral infections, increasing prevalence of respiratory syncytial virus, and increasing prevalence of hepatitis. Major trends in the forecast period include technological advancements, point-of-care testing, AI and data analytics, integration with digital health records, and next-generation sequencing.

The forecast of 7.6% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for viral antigen reagents and lateral flow assay components, sourced from key regions such as China and South Korea, could lead to testing shortages during outbreaks and increased diagnostic expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of viral infections is anticipated to drive the growth of the viral diagnostic test kits market in the coming years. Viral infections are caused by microscopic viruses that invade host cells, replicate within them, and can result in a wide range of symptoms, varying from mild to severe, affecting different parts of the body. This rise in infections is attributed to factors such as global travel, urbanization, climate change influencing vector-borne diseases, and the emergence of new viral strains capable of causing outbreaks or expanding into new regions. Viral diagnostic test kits play a crucial role in identifying and confirming specific viral infections by detecting viral nucleic acids (RNA or DNA), antigens, or antibodies in biological samples such as blood, saliva, or nasal swabs. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2022, there were 2,126 new cases of acute hepatitis B reported alongside 16,729 newly reported cases of chronic hepatitis B in the United States. Additionally, 14 jurisdictions in the US reported rates of acute hepatitis B higher than the national average, highlighting the need for effective diagnostic tools. Therefore, the increasing prevalence of viral infections is a key driver behind the growth of the viral diagnostic test kits market.

Leading companies in the viral diagnostic test kits market are focusing on developing innovative products, such as virus detection kits, to maintain their competitive edge. A virus detection kit is a diagnostic tool designed to detect specific viruses in biological samples, offering quick and accurate results to support effective disease monitoring and management. For example, in August 2024, BlueStain Global Ltd, a UK-based company, introduced the MPox virus detection kit. The Bluestain MPox virus detection kit is a rapid diagnostic test that identifies the mpox virus with high speed and accuracy, providing results in just 15 to 30 minutes. This innovative kit aims to improve public health responses by enabling early detection and containment of mpox outbreaks, especially in resource-limited environments.

In June 2023, Avacta Life Sciences, a UK-based company in the life sciences sector, completed the acquisition of Coris Bioconcept for £7.4 million ($9.35 million). This strategic move by Avacta is aimed at bolstering its rapid diagnostic test portfolio, thereby strengthening its capabilities in healthcare diagnostics and expanding its market presence, particularly in the fields of infectious disease management and point-of-care testing. Coris Bioconcept, based in Belgium, specializes in the development and manufacturing of rapid diagnostic test kits, primarily focusing on lateral flow tests designed to detect viral and bacterial pathogens.

Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Myriad Genetics Inc., Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc, Biodesix Inc.

North America was the largest region in the viral diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the viral diagnostic test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viral diagnostic test kits market consists of sales of viral culture kits, molecular diagnostic kits, antibody detection kits, antigen detection kits, and multiplex PCR kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viral Diagnostic Test Kits Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viral diagnostic test kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viral diagnostic test kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral diagnostic test kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test: Traditional Tests; Rapid Test
• 2) By Test Type: Direct Fluorescent Antibody (DFA) Test; Immunochromatographic Assay; Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test; Agglutination Assay; Solid Phase Assay; Flow Through Assay; Other Test Types
• 3) By End-User: Research Laboratories; Clinics; Hospitals; Other End Users
• Subsegments:
• 1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA); Polymerase Chain Reaction (PCR) Tests; Western Blot; Viral Culture Testing
• 2) By Rapid Test: Lateral Flow Assays (LFA); Immunochromatographic Strip Tests; Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP); Rapid Antigen Tests
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company; Quest Diagnostics Incorporated; Grifols S.A.; Hologic Inc.; PerkinElmer Inc.; bioMerieux SA; Quidel Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Ortho Clinical Diagnostics; Myriad Genetics Inc.; Seegene Inc.; OraSure Technologies Inc.; Meridian Bioscience Inc.; DiaSorin S.p.A.; Trinity Biotech plc; Biodesix Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Viral Diagnostic Test Kits Market Characteristics

3. Viral Diagnostic Test Kits Market Trends And Strategies

4. Viral Diagnostic Test Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Viral Diagnostic Test Kits Growth Analysis And Strategic Analysis Framework

• 5.1. Global Viral Diagnostic Test Kits PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Viral Diagnostic Test Kits Market Growth Rate Analysis
• 5.4. Global Viral Diagnostic Test Kits Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Viral Diagnostic Test Kits Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Viral Diagnostic Test Kits Total Addressable Market (TAM)

6. Viral Diagnostic Test Kits Market Segmentation

• 6.1. Global Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Traditional Tests
• Rapid Test
• 6.2. Global Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Fluorescent Antibody (DFA) Test
• Immunochromatographic Assay
• Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test
• Agglutination Assay
• Solid Phase Assay
• Flow Through Assay
• Other Test Types
• 6.3. Global Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Laboratories
• Clinics
• Hospitals
• Other End Users
• 6.4. Global Viral Diagnostic Test Kits Market, Sub-Segmentation Of Traditional Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Polymerase Chain Reaction (PCR) Tests
• Western Blot
• Viral Culture Testing
• 6.5. Global Viral Diagnostic Test Kits Market, Sub-Segmentation Of Rapid Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lateral Flow Assays (LFA)
• Immunochromatographic Strip Tests
• Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP)
• Rapid Antigen Tests

7. Viral Diagnostic Test Kits Market Regional And Country Analysis

• 7.1. Global Viral Diagnostic Test Kits Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Viral Diagnostic Test Kits Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viral Diagnostic Test Kits Market

• 8.1. Asia-Pacific Viral Diagnostic Test Kits Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viral Diagnostic Test Kits Market

• 9.1. China Viral Diagnostic Test Kits Market Overview
• 9.2. China Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viral Diagnostic Test Kits Market

• 10.1. India Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viral Diagnostic Test Kits Market

• 11.1. Japan Viral Diagnostic Test Kits Market Overview
• 11.2. Japan Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viral Diagnostic Test Kits Market

• 12.1. Australia Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viral Diagnostic Test Kits Market

• 13.1. Indonesia Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viral Diagnostic Test Kits Market

• 14.1. South Korea Viral Diagnostic Test Kits Market Overview
• 14.2. South Korea Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viral Diagnostic Test Kits Market

• 15.1. Western Europe Viral Diagnostic Test Kits Market Overview
• 15.2. Western Europe Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viral Diagnostic Test Kits Market

• 16.1. UK Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viral Diagnostic Test Kits Market

• 17.1. Germany Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viral Diagnostic Test Kits Market

• 18.1. France Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viral Diagnostic Test Kits Market

• 19.1. Italy Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viral Diagnostic Test Kits Market

• 20.1. Spain Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viral Diagnostic Test Kits Market

• 21.1. Eastern Europe Viral Diagnostic Test Kits Market Overview
• 21.2. Eastern Europe Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viral Diagnostic Test Kits Market

• 22.1. Russia Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viral Diagnostic Test Kits Market

• 23.1. North America Viral Diagnostic Test Kits Market Overview
• 23.2. North America Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viral Diagnostic Test Kits Market

• 24.1. USA Viral Diagnostic Test Kits Market Overview
• 24.2. USA Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viral Diagnostic Test Kits Market

• 25.1. Canada Viral Diagnostic Test Kits Market Overview
• 25.2. Canada Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viral Diagnostic Test Kits Market

• 26.1. South America Viral Diagnostic Test Kits Market Overview
• 26.2. South America Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viral Diagnostic Test Kits Market

• 27.1. Brazil Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viral Diagnostic Test Kits Market

• 28.1. Middle East Viral Diagnostic Test Kits Market Overview
• 28.2. Middle East Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viral Diagnostic Test Kits Market

• 29.1. Africa Viral Diagnostic Test Kits Market Overview
• 29.2. Africa Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viral Diagnostic Test Kits Market Competitive Landscape And Company Profiles

• 30.1. Viral Diagnostic Test Kits Market Competitive Landscape
• 30.2. Viral Diagnostic Test Kits Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Viral Diagnostic Test Kits Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company
• 31.2. Quest Diagnostics Incorporated
• 31.3. Grifols S.A.
• 31.4. Hologic Inc.
• 31.5. PerkinElmer Inc.
• 31.6. bioMerieux SA
• 31.7. Quidel Corporation
• 31.8. Sysmex Corporation
• 31.9. Bio-Rad Laboratories Inc.
• 31.10. QIAGEN N.V.
• 31.11. Ortho Clinical Diagnostics
• 31.12. Myriad Genetics Inc.
• 31.13. Seegene Inc.
• 31.14. OraSure Technologies Inc.
• 31.15. Meridian Bioscience Inc.

32. Global Viral Diagnostic Test Kits Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viral Diagnostic Test Kits Market

34. Recent Developments In The Viral Diagnostic Test Kits Market

35. Viral Diagnostic Test Kits Market High Potential Countries, Segments and Strategies

• 35.1 Viral Diagnostic Test Kits Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Viral Diagnostic Test Kits Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Viral Diagnostic Test Kits Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer